Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Journal of Neuroinflammation

Figure 1

From: Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion

Figure 1

Experimental timeline. Rats received either three sham injuries or three mild lateral fluid percussion injuries. After each injury rats were injected with their assigned treatment at 2 h and 24 h post-injury. After the final treatment, rats had either a short- (24 h) or long- (8 weeks) recovery period before behavioral testing. After behavioral testing, rats were sacrificed for histochemical and biochemical analyses.

Back to article page